Skip to main content
Clinical Trials/NL-OMON48446
NL-OMON48446
Withdrawn
Phase 4

Treatments for auditory verbal hallucinations in patients with borderline personality disorder: Cognitive Behavioural Therapy for hearing voices (CBT) and treatment with Flupentixol - CBT and Flupentixol for AVH in BPD

Parnassia (Den Haag)0 sites26 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Auditieve verbale hallucinaties
Sponsor
Parnassia (Den Haag)
Enrollment
26
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Parnassia (Den Haag)

Eligibility Criteria

Inclusion Criteria

  • Age 18 years or older, BPD confirmed with the Structured Clinical Interview for
  • DSM\-IV Axis II Personality Disorders (SCID II), AVH occurring at least daily,
  • and written informed consent for participation into this study from the

Exclusion Criteria

  • Pregnancy and schizophrenia spectrum disorders, except for 1\. Brief psychotic
  • disorder with hallucinations, and 2\. Other specific or nonspecific
  • schizophrenia spectrum and other psychotic disorder in case of persistent
  • auditory hallucinations.

Outcomes

Primary Outcomes

Not specified

Similar Trials